Rolf Stahel
Rolf Stahel
Verified email at usz.ch
Title
Cited by
Cited by
Year
Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer
International Adjuvant Lung Cancer Trial Collaborative Group
New England Journal of Medicine 350 (4), 351-360, 2004
26332004
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by …
M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ...
The lancet oncology 7 (5), 379-391, 2006
22252006
DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy
KA Olaussen, A Dunant, P Fouret, E Brambilla, F André, V Haddad, ...
New England Journal of Medicine 355 (10), 983-991, 2006
21692006
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
RA Olie, AP Simões-Wüst, B Baumann, SH Leech, D Fabbro, RA Stahel, ...
Cancer research 60 (11), 2805-2809, 2000
9072000
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ...
European Respiratory Journal 35 (3), 479-495, 2010
6532010
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the …
M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ...
The lancet oncology 12 (11), 1013-1022, 2011
6402011
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a …
DC Betticher, SFH Schmitz, M Tötsch, E Hansen, C Joss, C Von Briel, ...
Journal of clinical oncology 21 (9), 1752-1759, 2003
4592003
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells
S Aigner, ZM Sthoeger, M Fogel, E Weber, J Zarn, M Ruppert, Y Zeller, ...
Blood, The Journal of the American Society of Hematology 89 (9), 3385-3395, 1997
4141997
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
3862005
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
3822014
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma
W Weder, RA Stahel, J Bernhard, S Bodis, P Vogt, P Ballabeni, ...
Annals of oncology 18 (7), 1196-1202, 2007
3662007
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ...
Journal of Thoracic Oncology 5 (10), 1706-1713, 2010
3352010
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Péchoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
3242015
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
S Hopkins-Donaldson, A Ziegler, S Kurtz, C Bigosch, D Kandioler, ...
Cell Death & Differentiation 10 (3), 356-364, 2003
3222003
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma
W Weder, P Kestenholz, C Taverna, S Bodis, D Lardinois, M Jerman, ...
Journal of clinical oncology 22 (17), 3451-3457, 2004
2982004
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment …
J Lundin, A Osterborg, G Brittinger, D Crowther, H Dombret, A Engert, ...
Journal of Clinical Oncology 16 (10), 3257-3263, 1998
2961998
Circulating DNA: a new diagnostic gold mine?
A Ziegler, U Zangemeister-Wittke, RA Stahel
Cancer treatment reviews 28 (5), 255-271, 2002
2952002
Circulating deoxyribonucleic acid as prognostic marker in non–small-cell lung cancer patients undergoing chemotherapy
O Gautschi, C Bigosch, B Huegli, M Jermann, A Marx, E Chassé, ...
Journal of Clinical Oncology 22 (20), 4157-4164, 2004
2912004
Staging and prognostic factors in small cell lung cancer: a consensus report
RA Stahel, R Ginsberg, K Havemann, FR Hirsch, DC Ihde, J Jassem, ...
Lung cancer 5 (4-6), 119-126, 1989
2901989
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ...
Annals of Oncology 25 (9), 1681-1690, 2014
2882014
The system can't perform the operation now. Try again later.
Articles 1–20